Polygonum multiflorum-Induced Liver Injury: Clinical Characteristics, Risk Factors, Material Basis, Action Mechanism and Current Challenges

作者：Yi Liu, Wenping Wang, Mingyi Sun, Baorui Ma, Linnuo Pang, Yuanyuan Du, Xiaoxv Dong, Xingbin Yin, Jian Ni · 发表于：Frontiers in Pharmacology · 年份：2019 · DOI：10.3389/fphar.2019.01467 · 被引用次数：52 · 研究领域：Drug-Induced Hepatotoxicity and Protection、Phytochemistry and biological activity of medicinal plants、Pharmacological Effects of Natural Compounds

Praeparata (PMP) have been on the increase, especially with respect to liver injury. Most liver injury cases had been assessed for causality using RUCAM (Roussel Uclaf Causality Assessment Method) in this paper. However, the components of PM responsible for the reported hepatotoxic effects have not yet been identified. Moreover, many of the reports are contradictory, while studies on the mechanism involved in PM-induced liver damage are not comprehensive. This study was aimed at reviewing the status of research on liver injury due to PM, including clinical characteristics, risk factors, material basis research and mechanism of action, with a view to understanding PM-induced hepatotoxicity, and taking reasonable and effective measures to prevent it. In short, quality control is still one of the major safety problems in TCM drug safety concerns. The model of safety monitoring and risk management of PM drugs is not yet developed. Indeed, the characteristics and risk factors associated with PM require both proper understanding and control of the risk by strengthening standardization of clinical applications, basic science research, quality control in manufacturing, active monitoring methodology and enhancement of international communication and cooperation. Measures should also be encouraged and implemented to promote healthy development of the TCM industry.